EUVIMEDEUVIMED entdecken
Open Access

Harnessing the SPOP E3 Ubiquitin Ligase via a Bridged Proteolysis Targeting Chimera (PROTAC) Strategy for Targeted Protein Degradation

Zhijie Deng, Jerrel Catlett, Youngeun Lee iD, Qiong Wu, Zhongli Xu, Ling Xie, Xian Chen, Yan Xiong, H Ümit Kaniskan, Jian Jin iD

Journal of Medicinal Chemistry · 24.04.2025 · 68 (8) · 8634-8647

DOI: 10.1021/acs.jmedchem.5c00295 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, online erschienen am 09.04.2025. Verfasst von Zhijie Deng und 9 weiteren Autor:innen. Beteiligte Einrichtung: Mount Sinai Center for Therapeutics Discovery, Departments of Pharmacological Sciences, Oncological Sciences and Neuroscience, Tisch Cancer Institute…. Hauptthemen laut MEDLINE: Proteolysis, Ubiquitin-Protein Ligases, Repressor Proteins, Nuclear Proteins. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIH HHS, NCI NIH HHS, Office of the Director.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Proteolysis Targeting Chimeras (PROTACs) represent promising therapeutic modalities for degrading disease-causing proteins. However, the development of effective PROTACs has been limited by the availability of suitable E3 ligase ligands. In this study, we demonstrate for the first time that SPOP, an unexplored E3 ligase, can be recruited to degrade target proteins of interest. We developed a bridged PROTAC strategy and successfully discovered a proof-of-concept PROTAC degrader 9 (MS479), which recruits the E3 ligase SPOP by directly binding its substrate GLP as a bridge protein. This approach facilitates the polyubiquitination and subsequent degradation of BRD4/3/2 by the 26S proteasome. 9 effectively reduced the protein level of BRD4 short isoform in a time-, concentration-, GLP-, SPOP-, and ubiquitin-proteasome system (UPS)-dependent manner. Additionally, 9 effectively inhibited the proliferation of colorectal cancer (CRC) cells. Overall, our study expands the limited repertoire of the E3 ligases that can be harnessed for targeted protein degradation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ProteolysisUbiquitin-Protein LigasesRepressor ProteinsNuclear ProteinsHumansCell ProliferationProteasome Endopeptidase ComplexTranscription FactorsCell Cycle ProteinsUbiquitinationCell Line, TumorProteolysis Targeting ChimeraBromodomain Containing Proteins

Substanzen

Ubiquitin-Protein LigasesSPOP protein, humanRepressor ProteinsNuclear ProteinsProteasome Endopeptidase ComplexTranscription FactorsCell Cycle ProteinsBRD4 protein, humanProteolysis Targeting ChimeraBromodomain Containing Proteins

Autor:innen und Institutionen

  • Mount Sinai Center for Therapeutics Discovery, Departments of Pharmacological Sciences, Oncological Sciences and Neuroscience, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York 10029, U…
  • Department of Biochemistry and Biophysics, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, United States.

ORCID-Profile: Youngeun Lee, Jian Jin

Förderung

  • NIH HHS
  • NCI NIH HHS
  • Office of the Director

Zitieren

APA

Deng, Z., Catlett, J., Lee, Y., Wu, Q., Xu, Z., Xie, L., Chen, X., Xiong, Y., Kaniskan, H. Ü., & Jin, J. (2025). Harnessing the SPOP E3 Ubiquitin Ligase via a Bridged Proteolysis Targeting Chimera (PROTAC) Strategy for Targeted Protein Degradation. Journal of Medicinal Chemistry, 68(8), 8634-8647. https://doi.org/10.1021/acs.jmedchem.5c00295

Vancouver

Deng Z, Catlett J, Lee Y, Wu Q, Xu Z, Xie L, et al. Harnessing the SPOP E3 Ubiquitin Ligase via a Bridged Proteolysis Targeting Chimera (PROTAC) Strategy for Targeted Protein Degradation. Journal of Medicinal Chemistry. 2025;68(8):8634-8647. doi:10.1021/acs.jmedchem.5c00295

BibTeX
@article{Deng2025,
  author = {Deng, Zhijie and Catlett, Jerrel and Lee, Youngeun and Wu, Qiong and Xu, Zhongli and Xie, Ling and Chen, Xian and Xiong, Yan and Kaniskan, H Ümit and Jin, Jian},
  title = {Harnessing the SPOP E3 Ubiquitin Ligase via a Bridged Proteolysis Targeting Chimera (PROTAC) Strategy for Targeted Protein Degradation},
  journal = {Journal of Medicinal Chemistry},
  year = {2025},
  volume = {68},
  number = {8},
  pages = {8634--8647},
  doi = {10.1021/acs.jmedchem.5c00295}
}
Kostenlos starten →